Envestnet Asset Management Inc Biomarin Pharmaceutical Inc Transaction History

Envestnet Asset Management Inc

  • $302 Billion
  • Q3 2024

A detailed history of Envestnet Asset Management Inc transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Envestnet Asset Management Inc holds 52,912 shares of BMRN stock, worth $3.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52,912
Previous 98,427 46.24%
Holding current value
$3.51 Million
Previous $8.1 Million 54.1%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
SELL
$69.02 - $93.84 $3.14 Million - $4.27 Million
-45,515 Reduced 46.24%
52,912 $3.72 Million
Q2 2024

Aug 08, 2024
SELL
$74.43 - $92.22 $2.98 Million - $3.69 Million
-40,055 Reduced 28.92%
98,427 $8.1 Million
Q1 2024

May 13, 2024
SELL
$83.81 - $99.0 $1.5 Million - $1.77 Million
-17,902 Reduced 11.45%
138,482 $12.1 Million
Q4 2023

Feb 13, 2024
BUY
$76.22 - $98.51 $2.33 Million - $3.01 Million
30,584 Added 24.31%
156,384 $15.1 Million
Q3 2023

Nov 13, 2023
BUY
$85.07 - $94.48 $5.03 Million - $5.58 Million
59,095 Added 88.59%
125,800 $11.1 Million
Q2 2023

Aug 04, 2023
BUY
$86.68 - $100.3 $722,824 - $836,401
8,339 Added 14.29%
66,705 $5.78 Million
Q1 2023

May 11, 2023
BUY
$87.74 - $117.27 $225,404 - $301,266
2,569 Added 4.6%
58,366 $5.68 Million
Q4 2022

Feb 07, 2023
BUY
$80.93 - $108.63 $17,238 - $23,138
213 Added 0.38%
55,797 $5.77 Million
Q3 2022

Nov 10, 2022
BUY
$82.16 - $96.94 $135,071 - $159,369
1,644 Added 3.05%
55,584 $4.71 Million
Q2 2022

Aug 03, 2022
SELL
$71.48 - $86.85 $681,061 - $827,506
-9,528 Reduced 15.01%
53,940 $4.47 Million
Q1 2022

May 04, 2022
SELL
$74.28 - $92.69 $6.81 Million - $8.5 Million
-91,724 Reduced 59.1%
63,468 $4.89 Million
Q4 2021

Feb 04, 2022
BUY
$71.72 - $91.47 $293,263 - $374,020
4,089 Added 2.71%
155,192 $13.7 Million
Q3 2021

Oct 07, 2021
SELL
$74.77 - $85.47 $393,738 - $450,085
-5,266 Reduced 3.37%
151,103 $11.7 Million
Q2 2021

Aug 04, 2021
SELL
$75.51 - $84.79 $230,909 - $259,287
-3,058 Reduced 1.92%
156,369 $13 Million
Q1 2021

May 04, 2021
BUY
$74.73 - $90.69 $744,534 - $903,544
9,963 Added 6.67%
159,427 $12 Million
Q4 2020

Feb 02, 2021
BUY
$72.61 - $90.2 $83,428 - $103,639
1,149 Added 0.77%
149,464 $13.1 Million
Q3 2020

Oct 09, 2020
BUY
$71.87 - $131.03 $405,562 - $739,402
5,643 Added 3.96%
148,315 $11.3 Million
Q2 2020

Jul 08, 2020
BUY
$79.55 - $124.22 $631,388 - $985,934
7,937 Added 5.89%
142,672 $17.6 Million
Q1 2020

Apr 23, 2020
BUY
$71.37 - $96.85 $1.06 Million - $1.44 Million
14,853 Added 12.39%
134,735 $11.4 Million
Q4 2019

Feb 11, 2020
BUY
$64.27 - $86.37 $577,530 - $776,120
8,986 Added 8.1%
119,882 $10.1 Million
Q3 2019

Oct 17, 2019
SELL
$67.4 - $85.11 $5.87 Million - $7.41 Million
-87,074 Reduced 43.98%
110,896 $7.47 Million
Q2 2019

Aug 02, 2019
BUY
$80.35 - $93.9 $2.5 Million - $2.92 Million
31,058 Added 18.61%
197,970 $17 Million
Q1 2019

May 10, 2019
BUY
$84.2 - $98.62 $2.3 Million - $2.7 Million
27,364 Added 19.61%
166,912 $14.8 Million
Q4 2018

Feb 13, 2019
BUY
$80.14 - $106.07 $11.2 Million - $14.8 Million
139,548 New
139,548 $11.9 Million
Q3 2018

Nov 14, 2018
SELL
$93.92 - $105.72 $345,531 - $388,943
-3,679 Closed
0 $0
Q2 2018

Aug 10, 2018
BUY
$76.01 - $99.03 $27,363 - $35,650
360 Added 10.85%
3,679 $346,000
Q1 2018

May 09, 2018
BUY
$77.67 - $92.63 $121,786 - $145,243
1,568 Added 89.55%
3,319 $269,000
Q4 2017

Feb 20, 2018
BUY
$80.76 - $95.13 $36,018 - $42,427
446 Added 34.18%
1,751 $157,000
Q3 2017

Nov 13, 2017
SELL
$80.6 - $94.95 $95,430 - $112,420
-1,184 Reduced 47.57%
1,305 $120,000
Q2 2017

Aug 14, 2017
BUY
N/A
2,489
2,489 $226,000

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.3B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email